8月18日，京东美妆联合专业科学护肤品牌修丽可，重磅首发全新修丽可A.G.E.精华，为消费者带来更 加高效优质的功效护肤体验。同时，修丽可整全美学大使林允空降京东美妆采销直播间，分享"皮贴 骨"秘籍、演示护肤手法，还为粉丝抽取亲签照片、A.G.E.系列礼盒等多种奖品。丰富的直播福利和内 容吸引众多消费者围观，单日直播观看人次最高超110万人次，直播期间成交额环比增长18倍，带动修 丽可单日成交额环比增长翻倍，A.G.E.精华跃升京东修护型面部精华新品榜第1名。打开京东APP搜 索"修丽可新品精华"，全店爆款超买1送1量，更有定制防晒面罩限时加赠。 作为高端院线护肤品牌，修丽可率先提出"整全护肤"概念，深耕抗衰尖端成分与功效护肤赛道，打造出 A.G.E.面霜、色修精华、防晒小银伞等多款爆品。此次京东美妆携手修丽可全新首发的A.G.E.精华，延 续了同系列面霜中30%玻色因溶液这一最核心的配方，还添加鼠李糖、龙胆根提取物等成分，能补充胶 原并抵御胶原醣化流失，有效提升使用者全脸紧致度。首发期间在京东美妆下单A.G.E.精华，不仅加赠 19ml同款精华，更有修丽可定制防晒面罩限时赠送，带来抗老、防晒的一站式解决方案 ...

Core Viewpoint - The Chinese medical beauty market is rapidly expanding, with a market size of 217.9 billion yuan in 2021, projected to exceed 1 trillion yuan by 2030. The "perioperative skincare" segment is gaining traction, attracting over 20 beauty companies to enter the field [2]. Group 1: Market Expansion and Trends - The "perioperative skincare" segment is a professional blue ocean attracting major beauty brands, with international giants and emerging brands competing for growth [2]. - The concept of "holistic skincare" was first introduced by SkinCeuticals in China in 2012, establishing a scientific system and comprehensive product matrix in the perioperative skincare field [4]. Group 2: Academic Leadership and Events - SkinCeuticals has been invited to the IMCAS conference for 12 consecutive years, showcasing its academic strength and industry leadership through various dimensions [3]. - The IMCAS conference featured a satellite meeting led by Professor Xiang Lei Hong from Fudan University, discussing global trends in medical beauty and advancements in holistic skincare [6]. Group 3: Holistic Skincare Development - SkinCeuticals has established a mature "dual beauty" concept system under the holistic skincare philosophy, setting standardized guidelines for the industry [8]. - The brand emphasizes the synergy between effective skincare products and medical beauty projects, supported by clinical research and global case studies [9]. Group 4: Innovations and Product Launches - SkinCeuticals is expanding the holistic skincare concept into holistic aesthetics with the launch of the "SkinCeuticals Collagen Injection," the only human-derived collagen solution certified as a Class III medical device in China [15]. - The introduction of the A.G.E. serum, featuring 30% progerin solution and five patented anti-glycation technologies, highlights the brand's commitment to advanced anti-aging solutions [23]. Group 5: Industry Challenges and Solutions - The medical beauty industry faces challenges such as excessive marketing and misinformation, which can lead to safety risks for consumers [19]. - A roundtable forum was held to discuss the core needs of consumers and explore solutions to industry pain points, emphasizing a return to scientific principles in anti-aging practices [21].

Core Insights - The skincare market for international brands like Estée Lauder and L'Oréal is facing challenges, prompting a shift towards the medical aesthetics sector [1][4] - Estée Lauder has partnered with Jiahui Medical to establish a clinical research center focused on post-surgical skincare solutions [1][5] - The beauty industry is witnessing a trend towards "medical beauty," with brands integrating effective skincare products with medical aesthetics [4][6] Group 1: Company Strategies - Estée Lauder's brands, including La Mer and Clinique, are launching medical device products aimed at post-surgical recovery, indicating a strategic pivot towards medical aesthetics [1][5] - L'Oréal has been proactive in the medical aesthetics space, introducing products like the "Platinum Research" collagen injection and investing in high-end medical chains [6][7] - Amorepacific has also entered the market with its high-end brand "AP," focusing on post-surgical skincare products priced between 2000-3000 RMB [5][6] Group 2: Market Dynamics - The high-end skincare market is experiencing a significant decline, with Estée Lauder reporting an 8% drop in skincare sales in Q3 2024 and a further 12% in Q4 2024, leading to a total revenue loss of $300 million [4] - Competitors like Beiersdorf are also struggling, with its luxury brand La Prairie seeing a 15% sales decline in 2023 and a 6% drop in 2024 [4] - The domestic medical aesthetics market is becoming increasingly competitive, with companies like Aimeike facing growth slowdowns despite a 5.45% revenue increase in 2024 [9][10] Group 3: Future Outlook - Aimeike's acquisition of an 85% stake in Korean company REGEN for approximately 1.4 billion RMB highlights the need for companies to strengthen their technological capabilities in the face of rising competition [11] - The competition between international beauty brands and domestic medical aesthetics firms is intensifying, focusing on brand strength and clinical validation versus technological barriers and channel control [11]